the potential contributory role of an interaction between CD40 ϩ CD40 expression on graft infiltrates and parenchymal CD154 graft-destructive effector T cells and macrophages with CD154 ϩ (CD40L) induction in human chronic renal allograft rejection.
of late graft failure [1] . The underlying pathogenetic mechreceptor (TCR)␣/␤ was analyzed by immunohistochemistry.
anisms of chronic allograft rejection remain ill-defined. 
cardiac, and vascular allografts to be performed in animal
Results. Striking CD40 staining of graft cellular infiltrates models of CR [2] [3] [4] . Current concepts of CR obtained (P ϭ 0.016) was observed in renal allografts with CR compared from such experimental data implicate a multifactorial with controls. The CD40 ϩ cellular infiltrates in CR were predominantly TCR␣/␤ ϩ T cells and some CD68 ϩ macrophages. pathogenesis that involves both alloantigen-dependent These findings were contrasted by the low-level CD40 expresand -independent mechanisms [3, [5] [6] [7] [8] . tide-major histocompatibility complex on the antigen-Conclusion. In human chronic renal allograft rejection, CD40 presenting cell and signal 2 through interactions of cois expressed on graft-infiltrating cells of the T cell and macrostimulatory accessory molecules. Recent evidence has phage compartments. CD154 expression is induced on glomerimplicated the CD28/B7 and the CD40/CD154 (CD40L) ular and tubular epithelial cells during CR, demonstrating another novel source of CD154 expression. The data substantiate pathways in allograft rejection. Inhibition of the CD28/B7 pathway prolongs allograft survival [9, 10] . More interestingly, however, are recent reports of the induction of long-term graft acceptance concurrent with an absence rejection, in situ CD40 and CD154 expression was assessed in chronic rejecting allografts following human KTx. days after Tx  CAN score  Infiltrates  Tubules  Glomeruli  Infiltrates  Tubules  Glomeruli   1  3 6 4  5  0  0  1  2  1  2  3968  7  3  2  0  0  1  2  3  1065  5  3  1  1  4  533  8  2  2  0  1  2  5  5886  6 b  3  3  0  0  0  1  6  924  8  3  1  1  0  1  1  7  -a  12  3  3  1  0  0  3  8  -a  11  0  0  0  0  0  0  9  1326  7  1  2  1  0  0  3  10  3657  7  2  0  11  8725  12  3  0  1  12  428  5  1  0  3  1  13  476  -c  1  0  2  3  14  3290  4  1  1  0  0  3  3  15  747  6  1  0  0  2  16  1123  2  0  0  0  0  3  3  17  1231  7  2  1  2  3  18  755  5  3  0  0  1  3  3  19  688  2  3  1  0  3  0  1  20  5863  9  1  1  0  0  3  3  21  473  8  3  2  0  0  3  2  22  4862  4  3  0  3  1  23  167 Stable renal allograft biopsies in the control group con-University of Kentucky Transplant Center were colsisted of post-transplant protocol biopsies. lected and immediately snap frozen in methylbutane. Immunohistochemical analysis was performed on the Immunohistochemistry kidney allograft biopsies obtained from KTx patients CD40 and CD154 expression was analyzed by immuwith CR as the experimental group (N ϭ 23). Six stable nohistochemistry on serial cryostat sections of snap-frorenal allograft biopsies diagnosed as no rejection from zen kidney tissue. Immunostaining was performed using KTx patients and one normal kidney obtained at autopsy an indirect immunoperoxidase procedure with the Vecserved as the controls (N ϭ 7). The diagnosis of CR and tastain Elite ABC Kit (Vector, Burlingame, CA, USA). no rejection was based on criteria used as part of the Kidney biopsies were embedded in optimal cutting tem-Banff classification [15, 16] . Histological data of the experature (OCT) compound and snap frozen in dry ice/ perimental group are presented as chronic allograft nemethylbutane during sampling. Five-micrometer cryophropathy scores based on the Third Banff Conference stat sections were mounted on glass slides. Following on renal allograft pathology ( Table 1) [16]. The individparaformaldehyde fixation, endogenous peroxidase was ual chronic allograft nephropathy score was obtained by blocked using 0.3% H 2 O 2 /methanol, and the slides were the sum of each lesion quantitation scores of transplant washed in phosphate-buffered saline (PBS). For CD154 glomerulopathy (cg), interstitial fibrosis (ci), tubular atstaining, quenching of endogenous peroxidase was perrophy (ct), and vascular changes (cv). Twenty-two of the formed by incubation in glucose oxidase/glucose/sodium KTx patients were treated with the cyclosporine A-based azide solution for one hour, followed by PBS washing immunosuppressive regimen, which included azathio- [17] . Tissue sections were incubated with 5% horse seprine and methylprednisolone. Three KTx patients rerum for one hour, followed by blocking of endogenous ceived the FK506-based regimen, which also included biotin with the Avidin/Biotin blocking kit (Vector). The azathioprine and methylprednisolone. Five KTx patients slides were then incubated overnight with monoclonal were treated with azathioprine and methylprednisolone antibodies (mAbs) directed against human CD40 (clone but without either cyclosporine A or FK506. Renal allograft biopsies in the CR group were obtained late in the mAb89, mouse IgG1, diluted 1:150; Immunotech, West- brook, ME, USA) and CD154 (clone TRAP1, mouse mean staining intensity was performed using the Student's t-test. The correlation of CD40 and CD154 stain-IgG1, diluted to 1:200; Pharmingen, San Diego, CA, USA). Tissue sections were washed in PBS buffer and ing distribution with staining intensity of every structural compartment in each individual biopsy was analyzed by subsequently incubated with biotinylated horse antimouse IgG and avidin-biotin-horseradish peroxidase.
linear regression. All statistical analyses were performed using SigmaStat software. A P value of less than 0.05 Sections for CD154 staining were subjected to tyramide signal amplification (discussed later in this article) prior was considered significant. to incubation with chromogen. Chromogenic reaction was developed using aminoethyl carbonate (AEC) and RESULTS was counterstained with Mayer's hematoxylin. Serial sec-CD40 expression tions of snap-frozen renal allograft biopsies from the CR group were stained with anti-CD68 (clone EMB11, Moderate CD40 staining of graft infiltrates was detected in CR (1.938 Ϯ 0.306, mean staining intensity mouse IgG1, diluted 1:200; Dako, Carpinteria, CA, USA) as a marker for macrophages and anti-TCR␣/␤ score Ϯ sem, P ϭ 0.016; Tables 1 and 2; Figs. 1 and 2) , which contrasted to the absence of CD40 expression on (clone ␤F1, mouse IgG1, diluted 1:100; Endogen, Woburn, MA, USA) as a marker for T cells, as described the scanty infiltrates present in control specimens. The estimated mean distribution (Ϯ sem) of CD40 expression earlier here, to identify the phenotype of the CD40 ϩ graft infiltrates in the CR group.
on graft cellular infiltrates in CR allografts was at 60% (Ϯ 7%) and ranged from 10 to 100%. The extent of Tyramide signal amplification CD40 staining on graft infiltrates of CR correlated with the CD40 staining intensity scores (R ϭ 0.854, P Ͻ Cryostat sections for CD154 and TCR␣/␤ staining were subjected to a tyramide signal amplification step 0.001). CD40 ϩ infiltrates were seen around areas of CD154 ϩ tubules and glomeruli (discussed later here). using a commercially available amplification kit (New England Nuclear, Boston, MA, USA) according to the Moderate CD40 staining of proximal tubules and a few distal tubules was similarly demonstrated in both CR manufacturer's specifications. After incubation in avidinbiotin-horseradish peroxidase and PBS wash, sections (1.076 Ϯ 0.198) and controls (1.500 Ϯ 0.373). Only sparse glomerular CD40 expression in isolated cases of CR were incubated for 10 minutes in biotinyl tyramide solution and washed in PBS. Slides were then incubated (0.287 Ϯ 0.111) and controls (0.333 Ϯ 0.167) was detected. No CD40 immunoreactivity was detected on fi-in streptavidin-horseradish peroxidase for 30 minutes followed by a PBS wash. Chromogen was added and broblasts in areas of interstitial fibrosis and in the vasculature. counterstained as described earlier.
Data analysis
Serial anti-CD68 and anti-TCR␣/␤ staining of chronic rejection specimens Immunohistochemical sections were assessed blindly by two independent observers (A.S.G. and B.L.M.). The
To determine the phenotype of CD40 ϩ graft-infiltrating mononuclear cells in CR allografts, sequential stain-staining intensity was semiquantitatively scored (0 ϭ no staining, 1 ϭ weak, 2 ϭ moderate, 3 ϭ strong), and the ing with anti-CD68 and anti-TCR␣/␤ mAbs were performed on serial sections of eight CR specimens. The staining distribution (percentage estimate of positivity) in each structural compartment was assessed. The follow-CD40 ϩ cellular infiltrates were predominantly TCR␣/␤ ϩ with a mean (Ϯ sd) estimated distribution of 73% (Ϯ 5) ing specific compartments were assessed: glomeruli, tubules, vasculature, infiltrates, and fibroblasts in areas of (range 10 to 50%, P Ͻ 0.001) compared with only 27% (Ϯ 5, range 50 to 90%), which were CD68 ϩ (Fig. 2) . interstitial fibrosis. A statistical analysis comparing the Tables 1 and 2) , which contrasted to that of the al have shown CD40 expression on infiltrating leukocytes controls (0.6714 Ϯ 0.376). CD154 immunoreactivity was in acute rejecting human renal allografts [22] . These data detected on glomerular endothelial, mesangial, and epiare in contrast to the rare CD40 expression by control thelial cells of almost all CR specimens (Fig. 3) . The groups reported using normal human kidney tissue and extent of CD154 staining in glomerular structures correnonrejecting kidney allografts [23, 24] . The observed tulated with the staining intensity scores of CD154 (R ϭ bular expression of CD40 may play a yet undefined role 0.689, P Ͻ 0.001). A positive trend was observed in in kidney function, as it has been demonstrated to influthe moderate tubular CD154 immunoreactivity (1.429 Ϯ ence cell growth and survival. The data presented are in 0.283; Fig. 4 ), mostly seen in atrophic and intact proximal line with previous studies demonstrating the constitutive tubules and in a few distal tubules in CR compared with CD40 expression on tubular epithelial cells in culture controls (0.778 Ϯ 0.290). Only weak CD154 expression and in normal kidney, inflammatory renal diseases, and in the vasculature and infiltrates was detected in three acute rejecting renal allografts [22, 23, 25]. isolated cases of CR, which was absent in all control
The finding of enhanced CD154 expression predomicases. No CD154 staining was detected on fibroblasts in nantly in renal parenchyma of kidney allografts manifestfibrotic areas of CR.
ing histologic evidence of CR extends the broad cellular expression pattern of CD154. CD154, the ligand for DISCUSSION CD40, was initially thought to be expressed exclusively on activated T cells. Recent reports, however, have docu-The CD40 receptor belongs to the tumor necrosis factor receptor superfamily and is expressed on a variety mented a wide cellular distribution of CD154 expression on human dendritic
cells [26], B cells [26], endothelial of cell types, including B cells, T cells, monocytes/macro-

Fig. 3. Glomerular CD154 expression demonstrating intense mesangial (A, arrows), epithelial (B, arrowheads), and endothelial staining (C). (D)
The absence of glomerular CD154 expression in a renal allograft biopsy with stable graft function. Magnification ϫ400, AEC, Mayer's hematoxylin.
cells, renal tubular epithelium [23]
, smooth muscle cells, support and confirm their findings at the protein expression level of a lack of CD154 expression in the absence and macrophages of atherosclerotic lesions [27] , as well as acute rejecting heart allografts [28] . In human chronic of rejection and in immunologic quiescence. The minimal CD154 expression detected on the minor graft infiltrates, renal allograft rejection, CD154 is induced not only on glomerular microvascular endothelial cells but on glo-albeit seen only in cases of CR, suggests a different important source of CD154 in CR other than activated merular epithelial, mesangial cells, and tubular epithelial cells as well. The observed de novo CD154 expression T cells alone. The marked de novo expression of CD154 on glomerular and tubular structures in chronic rejecting during CR stands in contrast to the relative absence of CD154 expression in nonrejecting kidney allografts and renal allografts extends the available current data relative to the broad cellular distribution of CD154 and its normal kidney tissue. Zheng et al have recently reported the up-regulation of CD154 gene transcripts in acute potential importance in the pathogenesis of chronic kidney graft rejection. rejecting human renal allografts [24] . In accordance with their findings of low-level CD154 gene activation in non-A stimulation-dependent soluble form of CD154 (sCD154) exists and, like the membrane-bound CD154, rejecting renal allografts and normal kidney, these data possesses functional biological properties [29, 30] . Acti-cells, and strongly contrasts with the enhanced CD154 expression on glomerular and tubular structures. Fur-vated T cells have been reported to release sCD154 in vitro through intracellular proteolytic processing that thermore, the known concomitant membrane CD154 expression and sCD154 release strongly argue that sCD154 parallels the kinetics of cell surface CD154 expression [29, 31] . The observed CD154 immunoreactivity on glo-is being released in the relative absence of surface CD154 expression on infiltrating mononuclear cells during CR. merular and tubular epithelial cells therefore implicates the potential immunolocalization of sCD154 bound to
The sparse CD40 expression observed in glomeruli and tubules could be due to a CD154-mediated negative reg-CD40 on renal parenchymal cells during CR. However, the data presented refute the argument of a potential ulatory mechanism. sCD154 down-regulates CD40 expression of bystander cells in an autocrine and paracrine cross-reactivity with ␣-CD154 mAb. False immunoreactivity against shed CD154 bound to CD40 is unlikely, as manner in a cytokine-like fashion [29] . Given the enhanced glomerular and tubular CD154 expression, it is only minimal CD40 expression was observed on the same probable that concomitant sCD154 release by these same effects of CD40-mediated signaling through CD154 treatment have been directly attributed to NF-B activa-cells may act to repress or inhibit the expression of CD40.
An important consequence of CD40 interaction on tion, which is associated with IB degradation [40] . Studies of chronic allograft rejection pathology have antigen-presenting cells with CD154 on graft-specific CD4 ϩ T cells involves regulatory mechanisms crucial to emphasized the transplant vasculopathy lesions that are common to all solid organ allografts. In CR of the allo-the destructive process of graft rejection. These include the potentiation of antigen-presenting cell function and graft kidney, characteristic glomerular and tubular changes occur. Current concepts of CR obtained from T-cell priming, activation, and differentiation through up-regulation of cell surface costimulatory molecules, experimental data provide evidence for a central role of inflammatory mediators, which include cytokines and adhesion molecules, and provision of critical inflammatory mediators and cytokines that all contribute to graft chemokines, and growth factors in several CR allograft models [2] [3] [4] [5] [6] [7] [8] , and are clearly observed in human renal rejection pathology. Of interest, however, is the possibility of a bidirectional modulation of CD40-CD154 signaling allografts as well [41] [42] [43] [44] . In fact, selective therapeutic intervention preventing the development of CR is associ-mechanisms that may contribute to the destructive effector mechanisms of CR. Both CD40 and CD154 have ated with the down-regulation of these inflammatory mediator responses [45] . It is, therefore, tempting to been reported to be coexpressed in human cardiac allografts on both allograft endothelial cells and graft-infil-speculate that a consequence of CD40-CD154 interaction not only leads to provision of critical inflammatory trating T lymphocytes during acute rejection [28] and in atherosclerotic lesions [27] . In line with these findings, mediators like proinflammatory cytokines and chemokines by allograft-specific cellular effector cells, but, also these data demonstrating CD40 expression on recipient effector cells and CD154 induction on donor allografts by renal epithelial cells of the allograft. In addition to its role as a cognate ligand in CD40-mediated events, implicate a direct cross-talk between CD40 ϩ T cells and macrophages with CD154 ϩ glomerular and tubular epicurrent data suggest that direct CD154 signaling may thelial cells.
independently contribute to signal-transducing events The effects of CD40 ligation include not only the inthrough a direct costimulatory receptor function [46] . In duction of major histocompatibility complex and costifact, directly engaging CD154 leads to cytokine producmulatory molecule B7 expression, but also the provision tion [47, 48] . This assumption would not be surprising of inflammatory cytokines and chemokines by mononuas glomerular and tubular epithelial cells are known to clear cells [23, 27, 32] . A possible CD40 cross-linking on synthesize cytokines and chemokines directly in the en-CD40 ϩ -infiltrating graft lymphocytes and macrophages suing stages of chronic renal allograft rejection [49]. by the de novo expressed CD154 on glomerular and Evidence has already been presented demonstrating tubular epithelial cells could therefore induce the producthe importance of blocking the CD40/CD154 costimulation of inflammatory mediators known to be elaborated tory pathway in the induction of long-term allograft surduring CR. The sustained intragraft release of these povival and prevention of chronic allograft rejection in tentially graft destructive mediators may play a critical animal models [11, 13, 14] . The novel data presented in role in the pathology of chronic allograft rejection. The this study of de novo CD154 expression on renal allograft administration of CD154, which leads to CD40 ligation, parenchyma and graft-infiltrating CD40 ϩ T cells and induces potent biological effects on T cells and monomacrophages during CR may help elucidate the destruccytes promoting optimal activation, proliferation, and tive mechanisms of CD40/CD154 interactions that may cytokine production [33] [34] [35] . The production of these contribute to the development of human chronic renal mediators by CD40 ϩ graft infiltrates is likely, as these allograft rejection. cells have been demonstrated to produce inflammatory cytokines following direct CD40 engagement [23, 27, 32] .
NOTE ADDED IN PROOF In support of this hypothesis, the disruption of CD40/ The upregulated CD154 expression on Kupffer cells CD154 interactions that leads to the prevention of graft has recently been reported in human liver allografts durrejection is associated with the inhibition of proinflaming chronic ductopenic rejection [Gaweco AS, Wiesner matory and T helper type 1 (Th1) cytokines [11, 36] . Of RH, Yong S, Krom R, Porayko M, Chejfec G, McClatcritical importance, moreover, are recent reports attribchey KD, Van Thiel DH: CD40L (CD154) expression uting CD40 signaling in preventing apoptosis [37] . CD40 in human liver allografts during chronic ductopenic reengagement promotes the viability of mononuclear cells jection. Liver Transpl Surg 5:1 -7, 1999 ]. through antiapoptotic mechanisms [32, 37] . Recently, CD40-mediated signaling has been reported to activate ACKNOWLEDGMENTS nuclear factor-B (NF-B) [38] , thereby inducing its known antiapoptotic properties through the induction Parts of this study were presented at the 17 th Annual Meeting of the American Society of Transplant Physicians and the XVII World of antiapoptotic genes [39] . In fact, the antiapoptotic
